Newsletter

039200 - Oscotec, Inc.

039200 Summary
Biopharma
Stock Price & Overview
₩36,600 +700 (+1.95%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩36,600  ≈ US$26  ·  Market cap ₩1.4tn (≈ $1.0bn)
Why this page exists. Korean issuers file to DART, not the SEC, and almost nothing is published in English. Titles here are translated; where kstock has read the filing, the row carries the explanation and the amount in won and dollars. How we pick »

039200 DART Filings

DART

Material matter affecting investment judgment (clinical trial result)

Filing09/04/26title translated
DART

Half-Year Report

Periodic08/14/26title translated
DART

Share pledge that could change the largest shareholder

Filing07/23/26title translated
DART

Change of largest shareholder

Filing07/23/26title translated
DART

Material matter affecting investment judgment

Filing06/17/26title translated
DART

Material matter affecting investment judgment

Filing06/01/26title translated
DART

Material matter affecting investment judgment (clinical trial plan approval)

Filing05/22/26title translated
DART

Material matter affecting investment judgment

Filing05/14/26title translated
DART

Quarterly Report

Periodic05/14/26title translated
9 routine filings (insider holdings reports, IR schedules)DART

5% Ownership Report — Large Holdings

Ownership09/01/26title translated
DART

Investor Relations Event

IR08/20/26title translated
DART

5% Ownership Report — Large Holdings

Ownership08/14/26title translated
DART

5% Ownership Report — Large Holdings

Ownership07/23/26title translated
DART

Investor Relations Event

IR07/03/26title translated
DART

5% Ownership Report — Short Form

Ownership05/29/26title translated
DART

5% Ownership Report — Short Form

Ownership05/22/26title translated
DART

Investor Relations Event

IR05/14/26title translated
DART

Investor Relations Event

IR05/07/26title translated
18 filings on file, grouped where one event produced many. Source: DART, operated by Korea's Financial Supervisory Service.

Similar to 039200

SymbolLast Price
140410Mezzion Pharma Co., Ltd.₩65,000
+0.0%
068760Celltrion Pharm, Inc.₩40,850
+0.0%
007390Naturecell Co., Ltd.₩23,950
+0.2%
006280GC Biopharma Corp.₩127,600
+0.5%
950160Kolon Tissue Gene, Inc.₩17,100
+1.1%
069620Daewoong Pharma₩116,100
+1.1%
290650L & C BIO Co., Ltd.₩47,900
-1.4%
127120JS Link₩33,600
+12.4%
475830Orum Therapeutics, Inc.₩55,900
+2.6%
195940HK inno.N Corporation₩42,050
+0.7%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.